Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL217886 | 0.96 | KDM4E (0.31) | KDM4EALDH1A1HPGDHSD17B10GABRA1 | |
| SCHEMBL217789 | 0.96 | KDM4E (0.33) | KDM4EALDH1A1HPGDHSD17B10GABRA1 | |
| SCHEMBL10598219 | 0.92 | KDM4E (0.32) | KDM4EALDH1A1HPGDHSD17B10GABRA1 | |
| SCHEMBL4175469 | 0.88 | KDM4E (0.33) | KDM4EALDH1A1HPGDHSD17B10GABRA1 | |
| SCHEMBL13199170 | 0.85 | KDM4E (0.32) | KDM4EALDH1A1HPGDHSD17B10GABRA1 | |
| SCHEMBL5516684 | 0.83 | KDM4E (0.38) | KDM4EALDH1A1HPGDHSD17B10GABRA1 | |
| SCHEMBL13025134 | 0.81 | KDM4E (0.37) | KDM4EALDH1A1HPGDHSD17B10GABRA1 | |
| SCHEMBL12766214 | 0.80 | KDM4E (0.33) | KDM4EALDH1A1HPGDHSD17B10GABRA1 | |
| SCHEMBL19253093 | 0.78 | — | — | |
| SCHEMBL8351615 | 0.78 | KDM4E (0.35) | KDM4EALDH1A1HPGDHSD17B10GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102762532-B | The manufacture method of cyano group alkenyl cyclopropanecarboxylic acid salt | SUMITOMO CHEMICAL CO.,LTD. (JP) | 2015-07-29 | — | — | CN | disclosed |
| EP-1792889-B1 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL CO (JP) | 2015-03-04 | — | — | EP | disclosed |
| CN-102365264-B | Process for producing 3-(2-cyano-1-propenyl)-2,2- dimethylcyclopropanecarboxylic acid or salt thereof | SUMITOMO CHEMICAL CO | 2014-05-21 | — | — | CN | disclosed |
| EP-2418197-B1 | PROCESS FOR PRODUCING 3-(2-CYANO-1-PROPENYL)-2,2- DIMETHYLCYCLOPROPANECARBOXYLIC ACID OR SALT THEREOF | SUMITOMO CHEMICAL CO (JP) | 2014-05-07 | — | — | EP | disclosed |
| EP-1547995-B1 | Process for the preparation of carboxylic acid esters | SUMITOMO CHEMICAL CO (JP) | 2014-05-07 | — | — | EP | disclosed |
| EP-1758859-B1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | LILLY CO ELI (US) | 2013-07-17 | — | — | EP | disclosed |
| US-8461370-B2 | Process for producing 3-(2-cyano-1-propenyl)-2,2- dimethylcyclopropanecarboxylic acid or salt thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-06-11 | — | — | US | disclosed |
| EP-2537828-A1 | METHOD FOR PRODUCING CYANOALKENYLCYCLOPROPANECARBOXYLIC ACID SALT | Sumitomo Chemical Company, Limited (JP) | 2012-12-26 | — | — | EP | disclosed |
| US-20120310003-A1 | METHOD FOR PRODUCING CYANOALKENYLCYCLOPROPANECARBOXYLIC ACID SALT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-12-06 | — | — | US | disclosed |
| CN-102762532-A | Method for producing cyanoalkenylcyclopropanecarboxylic acid salt | SUMITOMO CHEMICAL CO | 2012-10-31 | — | — | CN | disclosed |
| CN-1369476-A | Process for prepn. of cyclopropane formic ether | SUMITOMO CHEMICAL CO (JP) | 2002-09-18 | — | — | CN | disclosed |
| US-6441220-B1 | ESTERIFICATION WITH ALCOHOL IN PRESENCE OF BASIC CATALYSTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-08-27 | — | — | US | disclosed |
| EP-1227077-A2 | Process for producing cyclopropanecarboxylates | Sumitomo Chemical Co.,Ltd. (JP) | 2002-07-31 | — | — | EP | disclosed |
| CN-1354166-A | Process for preparing cyclopropane carboxylic acid ester | SUMITOMO CHEMICAL CO (JP) | 2002-06-19 | — | — | CN | disclosed |
| EP-1203760-A1 | Method for producing cyclopropanecarboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-05-08 | — | — | EP | disclosed |
| US-20020052525-A1 | Method for producing cyclopropanecarboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-05-02 | — | — | US | disclosed |
| CN-1282729-A | Preparation method of cyclopropane carboxylic acid ester | SUMITOMO CHEMICAL CO (JP) | 2001-02-07 | — | — | CN | disclosed |
| EP-1061065-A2 | Methods for producing cyclopropane carboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-12-20 | — | — | EP | disclosed |
| CN-1255489-A | Method for preparing cyclopropane carboxylic ester | SUMITOMO CHEM ENG (JP) | 2000-06-07 | — | — | CN | disclosed |
| EP-0992479-A1 | Method for producing cyclopropanecarboxylates | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120310003-A1 | METHOD FOR PRODUCING CYANOALKENYLCYCLOPROPANECARBOXYLIC ACID SALT | MCCC2, AOC2, DDC | KDM4E 3274/4885ALDH1A1 809/4885HPGD 2540/4885 |
| US-20020052525-A1 | Method for producing cyclopropanecarboxylates | CYP8B1, SRD5A2, CYP21A2 | KDM4E 641/4885ALDH1A1 671/4885HPGD 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.